• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在表达人OAT1的MDCK细胞中甲基汞半胱氨酸S-共轭物的处理

Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1.

作者信息

Zalups Rudolfs K, Ahmad Sarfaraz

机构信息

Division of Basic Medical Sciences, Mercer University, School of Medicine, Macon, Georgia 31207, USA.

出版信息

Kidney Int. 2005 Oct;68(4):1684-99. doi: 10.1111/j.1523-1755.2005.00585.x.

DOI:10.1111/j.1523-1755.2005.00585.x
PMID:16164645
Abstract

BACKGROUND

The activity of the organic anion transporter 1 (OAT1) has been implicated recently in the basolateral uptake of thiol conjugates of inorganic mercury in renal proximal tubular cells. However, very little is known about the role of OAT1 in the renal epithelial transport of organic forms of mercury, such as methylmercury (CH(3)Hg(+)), especially when it is in the form of the cysteine (Cys) S-conjugate of methylmercury (CH(3)Hg-Cys), which is believed to be a biologically relevant form of mercury.

METHODS

Accordingly, the present study, was designed to characterize the transport of CH(3)Hg-Cys in Madin-Darby canine kidney (MDCK) cells transfected stably with the human isoform of OAT1 (hOAT1) and in proximal tubular-derived NRK-52E cells.

RESULTS

Data on saturation kinetics, time dependency, substrate specificity, and temperature dependency demonstrate that CH(3)Hg-Cys is transported by hOAT1. Substrate-specificity data from the control cells also show that CH(3)Hg-Cys is a substrate of one or more transporter(s) that is/are not hOAT1. Additional findings indicate that at least one amino acid transport system is involved in the uptake of CH(3)Hg-Cys in MDCK cells. Furthermore, in the presence of cytotoxic concentrations of CH(3)Hg-Cys, rates of survival were lower in hOAT1-transfected cells than in wild-type control cells.

CONCLUSION

The present data demonstrate clearly that CH(3)Hg-Cys is indeed a transportable substrate of OAT1. Moreover, the collective findings from the MDCK cells and NRK-52E cells infer that CH(3)Hg-Cys is a likely transportable mercuric species in proximal tubular epithelial cells that is taken up in vivo by both OAT1 and amino acid transporters.

摘要

背景

有机阴离子转运体1(OAT1)的活性最近被认为与肾近端小管细胞中无机汞硫醇结合物的基底外侧摄取有关。然而,关于OAT1在有机汞形式(如甲基汞(CH(3)Hg(+)))的肾上皮转运中的作用,人们了解甚少,尤其是当它以甲基汞的半胱氨酸(Cys)S结合物(CH(3)Hg-Cys)形式存在时,这种形式被认为是汞的一种生物学相关形式。

方法

因此,本研究旨在表征在稳定转染人OAT1同工型(hOAT1)的Madin-Darby犬肾(MDCK)细胞和近端小管来源的NRK-52E细胞中CH(3)Hg-Cys的转运情况。

结果

关于饱和动力学、时间依赖性、底物特异性和温度依赖性的数据表明,CH(3)Hg-Cys可被hOAT1转运。对照细胞的底物特异性数据还表明,CH(3)Hg-Cys是一种或多种非hOAT1转运体的底物。其他研究结果表明,至少一种氨基酸转运系统参与了MDCK细胞中CH(3)Hg-Cys的摄取。此外,在细胞毒性浓度的CH(3)Hg-Cys存在下,hOAT1转染细胞的存活率低于野生型对照细胞。

结论

目前的数据清楚地表明,CH(3)Hg-Cys确实是OAT1的可转运底物。此外,MDCK细胞和NRK-52E细胞的综合研究结果推断,CH(3)Hg-Cys可能是近端小管上皮细胞中一种可转运的汞物种,在体内可被OAT1和氨基酸转运体摄取。

相似文献

1
Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1.在表达人OAT1的MDCK细胞中甲基汞半胱氨酸S-共轭物的处理
Kidney Int. 2005 Oct;68(4):1684-99. doi: 10.1111/j.1523-1755.2005.00585.x.
2
Handling of the homocysteine S-conjugate of methylmercury by renal epithelial cells: role of organic anion transporter 1 and amino acid transporters.肾上皮细胞对甲基汞同型半胱氨酸S-共轭物的处理:有机阴离子转运体1和氨基酸转运体的作用
J Pharmacol Exp Ther. 2005 Nov;315(2):896-904. doi: 10.1124/jpet.105.090530. Epub 2005 Aug 4.
3
Transport of N-acetylcysteine s-conjugates of methylmercury in Madin-Darby canine kidney cells stably transfected with human isoform of organic anion transporter 1.甲基汞的N-乙酰半胱氨酸S-共轭物在稳定转染了人有机阴离子转运体1同种型的Madin-Darby犬肾细胞中的转运
J Pharmacol Exp Ther. 2005 Sep;314(3):1158-68. doi: 10.1124/jpet.105.086645. Epub 2005 May 20.
4
Homocysteine and the renal epithelial transport and toxicity of inorganic mercury: role of basolateral transporter organic anion transporter 1.同型半胱氨酸与无机汞的肾上皮转运及毒性:基底外侧转运体有机阴离子转运体1的作用
J Am Soc Nephrol. 2004 Aug;15(8):2023-31. doi: 10.1097/01.ASN.0000135115.63412.A9.
5
Human organic anion transporter 1 mediates cellular uptake of cysteine-S conjugates of inorganic mercury.人类有机阴离子转运蛋白1介导无机汞的半胱氨酸-S缀合物的细胞摄取。
Kidney Int. 2004 Jul;66(1):251-61. doi: 10.1111/j.1523-1755.2004.00726.x.
6
Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells.人肾有机阴离子转运体1介导的汞硫醇缀合物在Madin-Darby犬肾细胞中的摄取及毒性作用
Mol Pharmacol. 2003 Mar;63(3):590-6. doi: 10.1124/mol.63.3.590.
7
Renal organic anion transport system: a mechanism for the basolateral uptake of mercury-thiol conjugates along the pars recta of the proximal tubule.肾脏有机阴离子转运系统:近端小管直部基底外侧摄取汞硫醇结合物的一种机制。
Toxicol Appl Pharmacol. 2002 Aug 1;182(3):234-43. doi: 10.1006/taap.2002.9448.
8
System b0,+ and the transport of thiol-s-conjugates of methylmercury.系统b0,+与甲基汞硫醇-S-共轭物的转运
J Pharmacol Exp Ther. 2006 Nov;319(2):948-56. doi: 10.1124/jpet.106.109371. Epub 2006 Aug 22.
9
Luminal transport of thiol S-conjugates of methylmercury in isolated perfused rabbit renal proximal tubules.巯基 S- 结合物在分离的兔肾近端小管灌流中的亮氨酸转运。
Toxicol Lett. 2012 Sep 3;213(2):203-10. doi: 10.1016/j.toxlet.2012.07.003. Epub 2012 Jul 16.
10
Mouse monocytes (RAW CELLS) and the handling of cysteine and homocysteine S-conjugates of inorganic mercury and methylmercury.小鼠单核细胞(RAW细胞)以及无机汞和甲基汞的半胱氨酸和高半胱氨酸S-共轭物的处理
J Toxicol Environ Health A. 2007 May 15;70(10):799-809. doi: 10.1080/15287390701208644.

引用本文的文献

1
Advances in kidney disease: pathogenesis and therapeutic targets.肾病进展:发病机制与治疗靶点
Front Med (Lausanne). 2025 Feb 14;12:1526090. doi: 10.3389/fmed.2025.1526090. eCollection 2025.
2
Interaction of mercury species with proteins: towards possible mechanism of mercurial toxicology.汞物种与蛋白质的相互作用:探讨汞毒理学的可能机制。
Toxicol Res (Camb). 2023 May 30;12(3):355-368. doi: 10.1093/toxres/tfad039. eCollection 2023 Jun.
3
The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.
SLC22 转运蛋白家族:药物转运蛋白对代谢途径、信号转导和疾病影响的范例。
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:663-687. doi: 10.1146/annurev-pharmtox-010617-052713.
4
Chronic Kidney Disease and Exposure to Nephrotoxic Metals.慢性肾脏病与接触肾毒性金属
Int J Mol Sci. 2017 May 12;18(5):1039. doi: 10.3390/ijms18051039.
5
The aging kidney and the nephrotoxic effects of mercury.衰老的肾脏与汞的肾毒性作用
J Toxicol Environ Health B Crit Rev. 2017;20(2):55-80. doi: 10.1080/10937404.2016.1243501. Epub 2017 Feb 7.
6
Xenobiotic transporters and kidney injury.外源性物质转运体与肾损伤。
Adv Drug Deliv Rev. 2017 Jul 1;116:73-91. doi: 10.1016/j.addr.2017.01.005. Epub 2017 Jan 20.
7
Mechanisms involved in the transport of mercuric ions in target tissues.汞离子在靶组织中的转运机制。
Arch Toxicol. 2017 Jan;91(1):63-81. doi: 10.1007/s00204-016-1803-y. Epub 2016 Jul 15.
8
What do drug transporters really do?药物转运体到底在做什么?
Nat Rev Drug Discov. 2015 Jan;14(1):29-44. doi: 10.1038/nrd4461. Epub 2014 Dec 5.
9
Expression Profile of Drug and Nutrient Absorption Related Genes in Madin-Darby Canine Kidney (MDCK) Cells Grown under Differentiation Conditions.分化条件下培养的 Madin-Darby 犬肾(MDCK)细胞中药物和营养吸收相关基因的表达谱。
Pharmaceutics. 2012 Jun 18;4(2):314-33. doi: 10.3390/pharmaceutics4020314.
10
Evaluation of chinese-herbal-medicine-induced herb-drug interactions: focusing on organic anion transporter 1.中药诱导的药物相互作用评价:重点关注有机阴离子转运蛋白 1。
Evid Based Complement Alternat Med. 2012;2012:967182. doi: 10.1155/2012/967182. Epub 2012 Sep 4.